Apple to Launch Two New iPhones in 2014?
The latest scuttlebutt would suggest double the fun for Apple investors and iPhone aficionados: not one but two iPhone releases this year, each with a larger screen.
The latest scuttlebutt would suggest double the fun for Apple investors and iPhone aficionados: not one but two iPhone releases this year, each with a larger screen.
ThinkstockIn just a matter of days, the S&P 500 managed to produce a sell-off of more than 6%. The equity strategy team at Jefferies concede that the recent correction in share prices has raised…
ThinkstockGreece reportedly will announce a long-term bond sale as soon as Wednesday, the first time it has had access to capital markets since March 2010. But the question to ask is, is it too…
Sears Holdings continues to drop after completing its spin-off of Lands' End, which began trading Monday on the Nasdaq.
The recent violent sell-off has unnerved investors and given the bears the floor for the first time in a while. However, there are some positive signs that job growth and workforce participation are improving.
ThinkstockDespite a constant ongoing debate on Wall Street over the price of oil, the bottom line for investors is that oil prices for West Texas Intermediate continue to hover near the $100 mark. Combine…
In a new report, the Credit Suisse team says large cap biotech is cheaper than the S&P 500 on 2016 and 2017 numbers. Here are the top biotech names rated Outperform at Credit Suisse.
Criticism of high-frequency trading seems to have spooked investors in online brokers E*Trade and TD Ameritrade. Shares both of them are dropping for the second day in a row.
ThinkstockWhile the battle rages on Wall Street on which way the price of oil ultimately goes, investors in the refiners are watching close for a blowout in the difference between Brent crude and Louisiana…
Is Liberty Media's decision to reduce its stake in Barnes & Noble a matter of stepping aside so the bookseller can spread its wings, or is it throwing in the towel on the company…
Wikimedia CommonsLike most of the firms we follow on Wall Street, RBC has updated its top stocks picks for April. With first-quarter earnings right around the corner, and the stock market trading once again…
New drug innovations are affecting the way that physicians treat such debilitating and deadly diseases as cancer. In a new research report, Jefferies presents the top drug innovations that investors should follow for 2014.
ThinkstockA recent survey of chief information officers by UBS shows that expected information technology (IT) budget growth this year should be right-in-line with prior surveys. Most importantly, more than 60% of the CIOs are…
Intel may still be the world's largest chipmaker, but in many ways it is still playing catch-up with consumers' shift away from PCs to mobile devices. So it will establish a $100 million fund…
ThinkstockInvestors who own consumer discretionary stocks have been battered this year. The sector is down 4.53% and is the worst overall performer in the S&P. After being a market leader the past two years,…
courtesy of Cisco SystemsThe market exploded to end the first quarter, and once again investors are shaking their heads. After three months with much more volatility than all of 2013, we end up just…
Teva Pharmaceutical shares reached a new multiyear high Monday after the U.S. Supreme Court agreed to hear its appeal to revive a patent on its top-selling multiple-sclerosis drug.
Monday the state of New York joined a federal lawsuit against FedEx alleging that it illegally delivered 140 tons of contraband cigarettes in defiance of a 2006 agreement to cease the practice.
In a new research report, UBS analysts highlight five top technology stocks that, despite their solid credentials, may be ready to roll over. These stocks are overbought, but not over-the-hill.
Going against the grain can be good, especially in a market that feels a little toppy. In a new research report, Credit Suisse analysts highlight contrarian stocks to buy that go against the grain.